Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Stocks
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
2026-08-24
|
5-day change | 1st Jan Change | ||
| 35.72 CNY | +1.05% |
|
-1.22% | -21.70% |
| Market Cap | 23.78B 3.54B 3.03B 2.84B 2.59B 4.89B 339B 4.94B 33.55B 13.05B 170B 13.28B 12.99B 563B | P/E 2026 * |
26.7x | P/E 2027 * | 23.2x |
|---|---|---|---|---|---|
| Enterprise Value | 23.78B 3.54B 3.03B 2.84B 2.59B 4.89B 339B 4.94B 33.55B 13.05B 170B 13.28B 12.99B 563B | EV / Sales 2026 * |
4.82x | EV / Sales 2027 * | 4.44x |
| Free-Float |
31.71% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.05% | ||
| 1 week | -1.22% | ||
| Current month | -6.71% | ||
| 1 month | -2.43% | ||
| 3 months | -12.17% | ||
| 6 months | -17.37% | ||
| Current year | -21.70% |
| 1 week | 35.11 |  | 36.46 |
| 1 month | 35.11 | | 38.92 |
| Current year | 34.7 | | 48.2 |
| 1 year | 34.7 | | 50.95 |
| 3 years | 23.4 | | 50.97 |
| 5 years | 17.98 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Wang
CEO | Chief Executive Officer | 55 | 2017-10-09 |
Hong Zhou
PRN | Corporate Officer/Principal | 56 | - |
Mai Wang
PRN | Corporate Officer/Principal | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Xiu Mei Guo
BRD | Director/Board Member | 44 | 2018-12-23 |
Mai Wang
BRD | Director/Board Member | 56 | - |
Hong Zhou
BRD | Director/Board Member | 56 | 2019-05-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.05% | -1.22% | -23.25% | +2.97% | 3.54B | |
| +0.34% | -0.60% | -14.12% | -6.73% | 13.14B | |
| +0.04% | -2.70% | -35.89% | -57.90% | 4.85B | |
| -0.72% | -6.80% | -7.99% | -3.58% | 4.56B | |
| -3.71% | -6.88% | -2.46% | -30.28% | 3.94B | |
| +0.04% | +0.62% | -11.34% | -6.37% | 3.35B | |
| -1.00% | -3.52% | -13.18% | +12.02% | 3.29B | |
| -2.19% | -5.71% | -19.98% | -16.23% | 2.38B | |
| -0.65% | -4.04% | -30.80% | -12.54% | 1.66B | |
| +0.20% | +0.46% | -18.82% | +23.77% | 1.65B | |
| Average | -0.66% | -2.42% | -17.78% | -9.49% | 4.24B | |
| Weighted average by Cap. | -0.44% | -2.00% | -16.51% | -11.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.93B 733M 629M 588M 538M 1.01B 70.23B 1.03B 6.96B 2.71B 35.27B 2.75B 2.69B 117B | 5.35B 796M 682M 638M 583M 1.1B 76.21B 1.11B 7.55B 2.94B 38.27B 2.99B 2.92B 127B |
| Net income | 1.04B 154M 132M 124M 113M 213M 14.76B 215M 1.46B 568M 7.41B 579M 566M 24.51B | 1.18B 176M 151M 141M 129M 244M 16.86B 246M 1.67B 650M 8.47B 661M 647M 28.02B |
| Net Debt | - | - |
Employees
3,890
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-24 | CN¥35.72 | +1.05% | 2,780,150 |
| 26-08-21 | CN¥35.35 | -2.56% | 3,129,900 |
| 26-08-20 | CN¥36.28 | +1.77% | 3,177,569 |
| 26-08-19 | CN¥35.65 | -0.59% | 2,503,921 |
| 26-08-18 | CN¥35.86 | -0.83% | 2,168,810 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
35.72
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
